Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
30.48
-0.81 (-2.59%)
Jul 11, 2025, 12:15 PM - Market open
Viking Therapeutics Employees
Viking Therapeutics had 36 employees as of December 31, 2024. The number of employees increased by 9 or 33.33% compared to the previous year.
Employees
36
Change (1Y)
9
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$3,562,111
Market Cap
3.42B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VKTX News
- 1 day ago - Viking Therapeutics: What's Next After GLP-1 Hype Dies Down And Competition Intensifies - Seeking Alpha
- 7 days ago - Viking: I'm Bullish On Oral/Injectable GLP-1 Obesity Data Catalysts - Seeking Alpha
- 15 days ago - What's Going On With Viking Therapeutics Stock On Wednesday? - Benzinga
- 16 days ago - Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735 - PRNewsWire
- 5 weeks ago - Altimmune Vs. Viking Therapeutics: Evaluating Pipeline Maturity, And Takeover Potential - Seeking Alpha
- 6 weeks ago - Viking Therapeutics: Buy It For The Future And Ignore The Noise - Seeking Alpha
- 7 weeks ago - Viking Therapeutics: Weight-Loss Story Remains Intact - Seeking Alpha
- 7 weeks ago - Viking Therapeutics: A High Potential Biotech Play With Manageable Risks - Seeking Alpha